Key result
Surgical treatment for hypertrophic obstructive cardiomyopathy was associated with an 80% 10-year mortality rate versus 71% for medical therapy, despite more consistent symptom relief with surgery.
Why the study?
Does surgical treatment (septal myectomy) improve symptoms and reduce mortality compared to medical treatment in patients with hypertrophic obstructive cardiomyopathy?
Cohort (n=112)
Does surgical treatment (septal myectomy) improve symptoms and reduce mortality compared to medical treatment in patients with hypertrophic obstructive cardiomyopathy?
Absolute Event Rate: 80% vs 71%
Septal myectomy provides more consistent relief of symptoms and pressure gradients than medical therapy in HOCM, though long-term medical therapy with beta-blockers or verapamil also improves prognosis.
Questions routine surgical preference for survival benefit in HOCM; leaves open true comparative effectiveness versus medical therapy.
Sixty-three patients operated upon for HOCM and 49 patients selected for non-surgical treatment have been followed-up for 15 years. Pre-operatively, surgical patients had a higher left ventricular outflow tract gradient at rest and, on the average, more severe symptoms than non-surgical patients. Septal myectomy relieved the pressure gradient and symptoms more consistently than long-term treatment with beta-blockers or verapamil. Within an average observation time of 7 1/2 years, there was late deterioration or death in almost half of the non-surgical patients but in less than one-quarter in the operated patients. The 10 year mortality rate was 80% in the surgical series and 71% in the non-surgical series. In operated patients, pre-operative symptomatic status was significantly related to early and late mortality. In medically treated patients, mortality was unrelated to symptoms; however, it was significantly lower in patients receiving long term treatment with beta-blockers or verapamil. In conclusion, a high basal pressure gradient associated to limiting symptoms is a clear-cut indication for surgery. Other indications are more debatable. In medically treated patients, long-term administration of beta-blockers or verapamil is beneficial even without symptoms as it appears to improve prognosis.
No takes yet. Share an insight, caveat, or question.
Röthlin et al. (1983) conducted a cohort in Hypertrophic obstructive cardiomyopathy (n=112). Surgical treatment (septal myectomy) vs. Medical treatment (beta-blockers or verapamil) was evaluated on 10-year mortality rate. Surgical treatment for hypertrophic obstructive cardiomyopathy was associated with an 80% 10-year mortality rate versus 71% for medical therapy, despite more consistent symptom relief with surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: